Phase III study of interferon alfa-NL as adjuvant treatment for resectable renal cell carcinoma: an Eastern Cooperative Oncology Group/Intergroup trial.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples